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Abstract
One of the common complications associated with anaesthesia and surgery in geriatric 
patients is the postoperative cognitive dysfunction (POCD). This cognitive impairment 
affects the long-term prognosis and has been shown to be associated with long-term 
disability, higher health care costs, and even increased mortality. On the other hand, 
clinical research on POCD is in its infancy, the condition has not been clarified, and since 
no strategy for management is currently available, it is imperative to develop specific 
methods for prevention and management. Although its pathogenesis involves various 
factors, accumulating evidence suggests that surgery elicits an inflammatory response in 
the hippocampus, a brain area closely related to cognitive function, playing a key role in 
the development of POCD. Several studies suggest that age-related phenotypic change 
of microglia is associated with pathogenic neuroinflammation, and more importantly it 
may be modifiable. In this chapter, we discuss the current overview and preclinical high-
lights regarding POCD. We further discuss some perspectives on preventive strategies 
for POCD, based on the findings of our preclinical research and the available literature.
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1. Introduction
Sixty years ago, an article entitled Adverse cerebral effects of anaesthesia on old people by Dr. 
Bedfor was published in which he reported for the first time that general anaesthesia and sur-
gery led to cognitive dysfunction in elderly patients [1]. This decline, known as postoperative 
cognitive dysfunction (POCD), typically persists for several weeks, sometimes a year, but in 
some people is permanent. Since then, the number of publications assessing POCD has been 
growing year by year, reflecting the increasing importance and the still remaining controver-
sies over this condition [2].
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
One of the greatest achievements of modern medicine is the increase in life expectancy; 
howe ver, as a consequence the world population is today ageing fast, with over 12.3% of 
the total being over 60 years old [3]. Moreover, life expectancy increased by 5 years between 
2000 and 2015, the fastest growth since the 1960s [4]. Though it is one of our greatest achieve-
ments, it also poses big challenges as the ageing process is associated with biological and 
cognitive degeneration [5]. Recent advances in surgical, anaesthetic management and inten-
sive care techniques are associated with a growing number of elderly people undergoing 
surgical procedures [6]. Consequently, complications associated with geriatric surgery, such 
as POCD, will become an increasingly common worldwide problem [7, 8]. Furthermore, 
POCD has been shown to be associated with long-term disability and higher health care 
costs. In addition, three-month POCD has been statistically associated with increased mor-
tality [9].
POCD is difficult to define; in general it refers to a deterioration in cognition that occurs in the 
time period after surgery. To truly diagnose POCD, it is necessary to have tested the patient 
preoperatively (baseline) and determined how much of a decline occurred after surgery. As 
can be expected, in normal clinical contexts, patients do not usually undergo neuropsycho-
logical testing pre- and post-surgery [2, 10]. In consequence, there is a lack of accurate data 
and even the exact incidence of this condition is unknown [10]. Besides, behavioral responses 
to cognitive tests not only vary considerably in aged individuals compared with younger 
individuals, but also an enormous variability of cognitive decline exists across individuals 
[6, 11]. Additionally, the changes produced by the effects of ageing on cognitive function 
vary substantially through the different cognitive domains [11]. Likewise, different cognitive 
domains must be evaluated by specific tests [2]. Hence in order to diagnose and characterize 
POCD cases, it becomes necessary to carry out neuropsychological tests that assess different 
domains involved in cognitive function such as learning and memory, attention, psychomo-
tor function and flexibility cognition [2, 10]. In addition, POCD is sometimes characterized by 
slight declines in cognitive function, making it essential that these tests should be sensitive 
enough to allow an accurate diagnosis based on the results of pre-and postoperative tests [10]. 
As a consequence, incidence rates reported may vary considerably according to the cognitive 
domains explored by different tests and timing [12].
POCD was initially associated with cardiac surgery and indeed was recognized as the most 
common complication in this intervention, presenting a high incidence [13, 14], although the 
incidence values vary considerably between different reports, ranging from approximately 
30% to 80% at the time of discharge, 10–60% after 3–6 months and 20–60% after 6 months to 
1 year [12–20]. This fact may be related to microembolic events that may cause focal cerebral 
infarcts during the use of the cardiopulmonary bypass pump [12, 21–24].
In recent times, in correlation with the continuingly increasing number of patients under-
going geriatric surgery, the interest in POCD has expanded to noncardiac surgery as well. 
So far, the major study assessing this condition was carried out by the International Study 
of Postoperative Cognitive Dysfunction and included 1218 patients older than 60 years old 
undergoing elective, noncardiac surgery [7]. Neuropsychological tests were administered 
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before surgery and at 7 days and 3 months after intervention. This study reported a POCD 
incidence of 25% 1 week after surgery and 10% after 3 months. Additionally, the probability 
of POCD incidence in patients aged 70 and over at 3 months (14%) was two times higher than 
those aged 60 to 69 (7%). Hovens and collaborators [25] reported that the cognitive domains 
affected by cardiac surgery compared with noncardiac surgery seem to be different. While 
abdominal surgery affects hippocampal neuronal functioning and in consequence spatial 
memory, cardiac surgery seems to cause a more general change in inflammation and neuro-
nal function [25].
Furthermore, there appears to exist an association between postoperative pain and cognitive 
impairment, exerting an influence over the patients’ performance on certain cognitive tests 
[26–28]. Apart from the effect of the pain, the influence of postoperative analgesics should not 
be ruled out. In fact, successful postoperative pain management may be important in preven-
ting POCD in elderly patients [35]. Additionally, cognitive impairment in elderly patients 
may also be influenced by stress produced by the hospitalization itself, the postoperative 
fatigue state, the unfamiliar environment and sleep deprivation [12, 28, 29].
The contribution of the anaesthesia to the development of POCD seems to be subject to dis-
crepancies. When Silbert and colleagues [30] assessed general anaesthesia compared with 
spinal anaesthesia, no significant difference in the rates of POCD was found. In agreement 
with this, a meta-analysis carried on by Guay [31] did not find differences between general 
anaesthesia and regional anaesthesia with spontaneous breathing and sedation only in the 
development of permanent POCD after noncardiac surgery. Otherwise, another meta-analy-
sis concluded that general anaesthesia, compared to other types of anaesthesia, may increase 
the risk of developing POCD [32]. This findings are supported by preclinical studies, which 
suggest that isoflurane anaesthesia administered at clinically relevant doses causes long-
term cognitive impairment in unoperated animals [33–35]. However, other studies point 
towards an enhancement of the cognitive functions after anaesthesia inhalation [36–38].
Although major surgery is frequently associated with the development of POCD, minor 
surgery proved to decrease the cognitive function in the first postoperative week in elderly 
patients [39]. Moreover, independently from the nature of the surgical procedure, the only 
consistent risk factor that has been identified for POCD is advanced age [7, 9, 15, 39–41]. 
Apart from increasing age as a risk factor for POCD, other factors that can be enumerated are 
lower level of education, a history of previous cerebral vascular accident, a history of alcohol 
dependence, preoperative history of post-traumatic stress disorder, poor cognitive health, 
preceding development of POCD, respiratory complications, infectious complications and a 
second operation [9, 12, 41–43].
2. Mechanisms of POCD
One of the most challenging problems connected with POCD is the lack of evidence-based 
preventative strategies. This is due to the fact that the mechanisms that cause POCD in 
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elderly patients are largely unknown. In fact, surgery induces peripheral immune chal-
lenges, leading to an exaggerated neuroinflammatory response. More recently, several 
studies have demo nstrated that neuroinflammation in the hippocampus is most likely to 
be involved in the pathogenesis of POCD [35, 44–51]. Neuroinflammation is a complex 
response to brain injury characterized by maladaptive microglial activation mainly involv-
ing the activation of glia and increased levels of pro-inflammatory cytokines, including 
interleukin-1β (IL-1β) and tumour necrosis factor-α (TNF-α) [52–54]. As the primary source 
for pro-inflammatory cytokines, microglia are implicated as pivotal mediators of neuroin-
flammation. In particular, the hippocampus is known to be a region important to cognition 
and highly vulnerable to ageing. Pro-inflammatory cytokines TNF-α and IL-1β released 
from microglia within the hippocampus are reported to inhibit the long-term potentiation 
that is important in the formation of memory, as well as inducing apoptosis, and thus play 
a pathogenic role in cognitive disorders in neurodegenerative diseases [48, 52–58]. Based 
on these findings, it can be hypothesized that age-related microglial priming in the hip-
pocampus, and subsequent overproduction of inflammatory cytokines, plays a critical role 
in the development of POCD in the elderly population. Therefore, it becomes necessary to 
understand the roles of neuroinflammation in the pathogenesis of POCD and its potential 
as a therapeutic target.
Preclinical evidence has shown that microglia in a normal-aged brain are shifted towards 
the inflammatory phenotype (Figure 1). This age-related phenotype change is consistent 
with the microglial priming, implying that age-related microglia priming could make 
elderly surgical patients more susceptible to the development of POCD. Neurogenic neu-
roinflammation is the inflammatory reaction in the central nervous system in response to 
neuronal activity [59]. Peripheral immune challenges, such as surgical trauma, may lead 
neurogenic neuroinflammation to become maladaptive [60]. It has been postulated that the 
inflammatory response may be transmitted through humoral and neural pathways, leading 
to neuroinflammation. Parabiotic experiments in rat models have revealed that the neural 
pathway may play a dominant role in the development of neuroinflammation after abdomi-
nal surgery [60]. These findings seem to confirm the neurogenic neuroinflammatory origin 
of POCD in aged rats. Though rodents are useful in providing hypothetical models for 
understanding some of the memory deficits seen in human POCD, it still remains unclear 
how much can be extrapolated to simulate the neuroinflammatory mechanisms involved in 
human POCD [2].
While several studies have concentrated on protein regulating inflammation (cytokines), 
recent evidence points to a critical role of microRNAs (miRNAs) in controlling the inflam-
matory process [61–64]. A subset of miRNAs notably affects both immune and neuronal 
functions in particular in the central nervous system. It has been hypothesized that miRNAs 
regulate neuro-immune functions through alterations of neuron-glia and/or brain-to-body 
signalling [65]. Moreover, miR-572 has been implicated in the development and restoration of 
POCD and identified as a possible biological marker for early diagnosis of POCD [61]. In fact, 
modulating miRNAs using agonist or antagonist miRNAs is a promising approach to treating 
human neuroinflammatory disorders including POCD.
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3. Treatment and prevention
Notwithstanding the fact that POCD is a common complication for geriatric patients, currently 
there is not any available st ment after general anaesthesia [66]. Additionally, due to the 
challen ging nature of POCD, examples of randomized controlled studies assessing possible 
intervention for treating or improving POCD are scarce [2]. However, this can be addressed 
by studies assessing the effects of drugs on cognitive impairment after general anaesthesia. 
Aminophylline reduced the time necessary for postoperative cognitive recovery from sevo-
flurane anaesthesia, improving the ventilatory elimination of sevoflurane [67]. Meanwhile, 
low-dose haloperidol prophylactic treatment did not prove effective in decreasing the inci-
dence of postoperative delirium but had a positive effect on the severity and duration [68]. A 
pilot, phase 2a study to evaluate the feasibility, safety and efficacy of donepezil in preventing 
Figure 1. Microglial priming. Effects of ex vivo stimulation with lipopolysaccharide (LPS) on the cultured microglia 
were shown. Hippocampal microglia were isolated from either young or aged rats. Primary microglia were stimulated 
with 0.1, 1, 10 and 100 ng/ml or media alone, and levels of TNF-α were determined from supernatants collected 24 h 
later. The LPS-induced increase in TNF-α was greater in the microglia of aged rats than young. These results indicate 
that normal ageing may prime microglia for an exaggerated responsiveness to pro-inflammatory stimuli.
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postoperative delirium did not find significant changes in the incidence of delirium or in 
the days patients stayed in the hospital, although it did not rule out possible benefits [69]. 
In agreement with these results, Doraiswamy and collaborators [70] evaluated the effect of 
donepezil in treating patients with cognitive decline following coronary artery bypass graft 
surgery, reporting that donepezil did not improve composite cognitive performance but had 
enhancing effects on some aspects of memory. Meanwhile, the use of gabapentin in the treat-
ment of postoperative pain reduced the occurrence of post operative delirium [71].
Therefore, the lack of an effective treatment for POCD highlights the importance of the pre-
vention. Over the past years, research efforts have been directed to identifying new strate-
gies for preventing POCD [2]. While lidocaine administered during and after cardiac surgery 
failed to reduce POCD incidence, some protective effects of lower-dose lidocaine in nondi-
abetic subjects were found [72]. Moreover, due the anti-inflammatory action of ketamine, 
POCD incidence was reduced one week after cardiac surgery [73]. Meanwhile, intraopera-
tively intravenous administration of magnesium in cardiac surgery did not have any preven-
tive effect over POCD [74]. Furthermore, administration of a post-cardiac surgery high dose 
of dexamethasone failed to reduce the risk of POCD [75], while in another study, a higher 
dose of dexamethasone actually increased the incidence of POCD in the early postopera-
tive period after microvascular decompression under general anaesthesia [76]. Furthermore, 
resveratrol showed anti-neuroinflammation and anti-apoptosis effects attenuating the hip-
pocampus-dependent cognitive impairment induced by isoflurane in aged mice [77]. Also, 
ondansetron administered postoperatively appears to have analgesic and protective effects, 
additionally seeming to improve the cognitive function in patients undergoing surgery under 
general anaesthesia [78]. When the effects of postoperative analgesia with ketoprofen on cog-
nitive functions were investigated in aged animals, the results suggested that ketoprofen 
can prevent the development of surgery-associated memory deficits via its pain-relieving 
effects [79]. Chronic pretreatment with low doses of candesartan may elicit blood pres-
sure-independent neuroprotective effects in POCD by decreasing hippocampal blood-
brain barrier permeability and promoting resolution of neuroinflammation [47]. Further, 
dexmedetomidine provided neurocognitive protection, attenuating isoflurane-induced 
injury in rats developing brain [80]. Atorvastatin preserved the hippocampal-dependent 
fear response and also protected spatial memory on day seven after surgery in a mouse 
model of postoperative cognitive decline [81]. Aspirin-triggered resolvin D1 prevented 
neuronal dysfunction and cognitive decline after peripheral orthopaedic surgery in the 
mouse model [82].
There is considerable evidence that cognitive interventions, such as physical activity and 
cognitive activity, have positive effects on age-related cognitive changes as well as early-
stage dementia in humans [83–89]. In addition, animal models mimicking these inter-
ventions, in which rodents were exposed to voluntary wheel running and an enriched 
environment, showed improvement in cognitive performance (Figure 2) [48, 90]. Although 
the mechanism of these benefits has been debated, both interventions are reported to have 
common positive effects on microglial number, proliferation and phenotype in the brain. 
In fact, preoperative cognitive intervention, a combination of physical activity and cog-
nitive activity, has been shown to prevent the development of POCD via restoration of 
the pro-inflammatory phenotype in aged microglia [48]. In addition, evidence suggests 
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that an enriched environment attenuated the surgery effects in reduction of brain-derived 
neurotrophic factor (BDNF) expression and neurogenesis in the hippocampus [90]. Recent 
time-course analysis using a rat abdominal surgery model revealed that hippocampal 
neuroinflammation and related microglial activation were found at 7 days after surgery, 
which resolved to normal levels by 14 days after surgery [48]. Therefore, the effects of pre-
operative cognitive intervention may persist long enough to encompass the critical period 
of POCD development [48].
Figure 2. Effects of preoperative cognitive intervention on cognitive function assessed by novel object recognition test 
in aged rats. All rats were exposed to preoperative cognitive intervention or sedentary condition for 14 days following 
surgery (laparotomy and small intestinal manipulation) or non-surgery and allowed 7 days of recovery. Seven days 
after surgery, the effects of cognitive intervention on hippocampal-mediated working memory were assessed by a novel 
object recognition task. The sedentary rats in the aged group exhibited significantly impaired novel object recognition 
performance as shown by the similar amount of time spent in exploring the two objects. However, such impairment was 
not observed in the preoperative cognitive intervention group.
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4. Concluding remarks
POCD is increasingly recognized as one of the common complications in geriatric patients 
despite the lack of strategy for prevention and management. Due to these limitations, pre-
operative management should be focused on promoting an early recognition of the patients 
at risk, and preventative measures should be taken from a multimodal approach compri sing 
collaboration between the anaesthesiologist, surgeon, geriatricians and inclusion of fami ly 
in the postoperative care plan in order to improve overall recovery and avoid long-term 
sequelae of POCD [2, 6, 10, 66]. Furthermore, it is recommended that patients at high risk for 
POCD should get preoperative discussion of this issue, allowing patients to make cognitively 
demanding decisions before surgery [2]. In addition, in line with the positive effects of cogni-
tive interventions in both human and animal models, “pre-surgical rehabilitation” must be 
encouraged when possible in order to minimize the risk of POCD occurrence and its effects 
on overall recovery after surgery [2]. Moreover, promising new approaches such as the uti-
lization of the relationship between neuroinflammation and miRNA expression should not 
be overlooked, in order to understand and discover new treatments. Deregulation of certain 
miRNAs may be associated with POCD development.
While both cardiac surgery and noncardiac surgery have been associated with POCD, the effects 
of each seem to affect different cognitive domains and in consequence may originate from dif-
ferent causes or mechanisms [25]. Moreover, the difficulty extrapolating the knowledge gathe-
red through preclinical studies and animal models to human cases and the translation of these 
findings into therapeutic treatment for POCD points to the need for further work is needed. So 
far, the surgery-induced neuroinflammation processes including the microglial activation path-
ways seem to be the most promising therapeutic targets in the management of POCD.
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